Breast Cancer Thought Leader Engagement Lead . 29 yrs @Pfizer. Passionate about making a difference in cancer. Father. Foodie. My ops are my own. #PFEColleague
As I return from my 21st @asco, I am proud to represent @pfizer with Dalya Gayed, our new US Breast Cancer Franchise commercial lead. Through impactful discussions with national & global thought leaders, we strengthened our path forward in breast cancer @myESMO@SABCSSanAntonio
This Mother’s Day, I honor my Indian Mom for her love, strength, and wisdom that still guides me every day. Though she left us in 2009, her warmth, faith, sacrifices, traditions, and passion for cooking live through me. I miss her always and carry her in my heart forever. ❤️
Excited to be back in Berlin for #ESMOBC26 representing @pfizer. Looking forward to learning about new advances in breast cancer, collaborating with colleagues, and engaging with the global oncology community to improve outcomes for patients. @ASCO@myESMO@SABCSSanAntonio
Great sessions and excellent faculty in the inaugural Gulf of Naples conference. What a brilliantly crafted scientific forum and think tank put together by Antonio Giordano and colleagues. So honored to support and attend @DFCI_BreastOnc@antgiorda#GON2026
April 22, 2026 milestone. 30 years at Pfizer today. Grateful for a journey filled with growth, learning, and purpose since 1996. Thankful to mentors, colleagues, family, and friends for their support. Proud of the impact we’ve made for patients—and excited for what’s ahead.
As we bid farewell to 2025, I’m deeply grateful to my family, friends, colleagues & the oncology community. Thank you for your guidance, trust & support in making a positive impact on lives. Wishing you a great holiday, Merry Christmas & a Happy New Year. Looking forward to 2026.
Congratulations @stolaney1 honoring your contribution to the oncology community & the patients through your commitment as an outstanding investigator. Couldn’t think of anyone currently in the field more deserving. @SABCSSanAntonio@ASCO@myESMO@AACR@DFCI_BreastOnc
Sara Tolaney, MD, MPH (@stolaney1) delivering the #SABCS25 Outstanding Investigator Award for Breast Cancer Research. Dr. Tolaney's leadership in establishing biomarker-driven personalized therapy approaches for cancer, including the development of CDK4/6 inhibitors, has significantly advanced care in both metastatic and adjuvant settings, shaping the future of precision oncology for patients with #BreastCancer. @AACR@BCRFcure